MIRA Pharmaceuticals Inc. (MIRA)
1.17
0.00 (0.00%)
At close: Jan 15, 2025, 2:46 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -11.98K | -7.06M | -2.18M | -203.98 |
| Depreciation & Amortization | 732.29K | n/a | n/a | n/a |
| Stock-Based Compensation | 2.55M | 1.30M | n/a | n/a |
| Other Working Capital | 390.38K | 146.58K | 776.01K | n/a |
| Other Non-Cash Items | -9.31M | 10.25K | 24.37K | n/a |
| Deferred Income Tax | 401.39K | n/a | n/a | n/a |
| Change in Working Capital | 849.93 | 146.58K | 776.01K | n/a |
| Operating Cash Flow | -5.63M | -5.60M | -1.38M | -203.98 |
| Capital Expenditures | -1 | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | -160.00K | 203.06K | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 8.78K | 402.19K | -520.85K | 213.36 |
| Financial Cash Flow | 8.78K | 3.15M | 4.18M | 213.36 |
| Net Cash Flow | 4.25K | -2.46M | 2.81M | 3.13K |
| Free Cash Flow | -4.53K | -5.60M | -1.38M | -203.98 |